Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 3
2015 1
2016 4
2017 1
2018 1
2019 3
2020 3
2021 1
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
[Potentiation strategies].
Doumy O, Bennabi D, El-Hage W, Allaïli N, Bation R, Bellivier F, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courvoisier P, d'Amato T, Garnier M, Haesebaert F, Bougerol T, Lançon C, Moliere F, Nieto I, Richieri R, Saba G, Courtet P, Vaiva G, Leboyer M, Llorca PM, Aouizerate B, Haffen E. Doumy O, et al. Among authors: charpeaud t. Presse Med. 2016 Mar;45(3):338-49. doi: 10.1016/j.lpm.2016.02.004. Epub 2016 Mar 10. Presse Med. 2016. PMID: 26970936 Review. French.
[Other therapeutic strategies].
Saba G, Nieto I, Bation R, Allaïli N, Bennabi D, Moliere F, Richieri R, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courtet P, Courvoisier P, Haesebaert F, Doumy O, El-Hage W, Garnier M, d'Amato T, Bougerol T, Lançon C, Haffen E, Llorca PM, Vaiva G, Bellivier F, Leboyer M, Aouizerate B. Saba G, et al. Among authors: charpeaud t. Presse Med. 2016 Mar;45(3):350-9. doi: 10.1016/j.lpm.2016.02.005. Epub 2016 Mar 16. Presse Med. 2016. PMID: 26995510 Review. French.
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group. Di Forti M, et al. Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19. Lancet Psychiatry. 2019. PMID: 30902669 Free PMC article.
[Mixed states].
Llorca PM, Charpeaud T, Samalin L. Llorca PM, et al. Among authors: charpeaud t. Encephale. 2012 Dec;38 Suppl 4:S179-85. doi: 10.1016/S0013-7006(12)70097-0. Encephale. 2012. PMID: 23395234 Review. French.
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study.
Rodríguez-Toscano E, Alloza C, Fraguas D, Durán-Cutilla M, Roldán L, Sánchez-Gutiérrez T, López-Montoya G, Parellada M, Moreno C, Gayer-Anderson C, Jongsma HE, Di Forti M, Quattrone D, Velthorst E, de Haan L, Selten JP, Szöke A, Llorca PM, Tortelli A, Bobes J, Bernardo M, Sanjuán J, Luis Santos J, Arrojo M, Tarricone I, Berardi D, Ruggeri M, Lasalvia A, Ferraro L, La Cascia C, La Barbera D, Menezes PR, Del-Ben CM; EU-GEI WP2 Group; Rutten BP, van Os J, Jones PB, Murray RM, Kirkbride JB, Morgan C, Díaz-Caneja CM, Arango C. Rodríguez-Toscano E, et al. Schizophr Bull. 2023 Sep 7;49(5):1269-1280. doi: 10.1093/schbul/sbad013. Schizophr Bull. 2023. PMID: 37467351
[How to define treatment-resistant depression?].
Holtzmann J, Richieri R, Saba G, Allaïli N, Bation R, Moliere F, Nieto I, Bellivier F, Bennabi D, Bubrovszky M, Camus V, Charpeaud T, Courvoisier P, Haesebaert F, Doumy O, Courtet P, El-Hage W, Garnier M, d'Amato T, Lançon C, Leboyer M, Llorca PM, Vaiva G, Bougerol T, Aouizerate B, Haffen E. Holtzmann J, et al. Among authors: charpeaud t. Presse Med. 2016 Mar;45(3):323-8. doi: 10.1016/j.lpm.2016.02.002. Epub 2016 Mar 9. Presse Med. 2016. PMID: 26970938 Review. French.
Pharmacotherapeutic approaches to treating depression during the perimenopause.
Garay RP, Charpeaud T, Logan S, Hannaert P, Garay RG, Llorca PM, Shorey S. Garay RP, et al. Among authors: charpeaud t. Expert Opin Pharmacother. 2019 Oct;20(15):1837-1845. doi: 10.1080/14656566.2019.1645122. Epub 2019 Jul 29. Expert Opin Pharmacother. 2019. PMID: 31355688 Review.
[Switching and combining strategies of antidepressant medications].
Charpeaud T, Moliere F, Bubrovszky M, Haesebaert F, Allaïli N, Bation R, Nieto I, Richieri R, Saba G, Bellivier F, Bennabi D, Holtzmann J, Camus V, Courtet P, Courvoisier P, d'Amato T, Doumy O, Garnier M, Bougerol T, Lançon C, Haffen E, Leboyer M, Llorca PM, Vaiva G, El-Hage W, Aouizerate B. Charpeaud T, et al. Presse Med. 2016 Mar;45(3):329-37. doi: 10.1016/j.lpm.2016.02.003. Epub 2016 Mar 16. Presse Med. 2016. PMID: 26995511 Review. French.
28 results